Transient downregulation of monocyte-derived dendritic-cell differentiation, function, and survival during tumoral progression and regression in an in vivo canine model of transmissible venereal tumor

Cancer Immunology, Immunotherapy

Volumn 57, Issue 4, 2008, Pages 479-491

  Liu, Cheng Chi ^a   Wang, Yu Shan ^a,b   Lin, Ching Yi ^a   Chuang, Tien Fu ^a   Liao, Kuang Wen ^c   Chi, Kwan Hwa ^b   Chen, Mo Fan ^a   Chiang, Hsin Chien ^a   Chu, Rea Min ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c Institute of Bioinformatics and Structural Biology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; BIOLOGICAL MARKER; CD40 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; T6 ANTIGEN;

ANIMAL CELL; ANIMAL VENEREAL TUMOR; ARTICLE; CANCER GROWTH; CANCER REGRESSION; CELL ACTIVITY; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DOG; DOWN REGULATION; FLOW CYTOMETRY; HISTOCOMPATIBILITY COMPLEX; IN VIVO STUDY; LYMPHOID CELL LINE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD; CELL DIFFERENTIATION; CELL SURVIVAL; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOG DISEASES; DOGS; DOWN-REGULATION; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTES, TUMOR-INFILTRATING; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR ESCAPE; VENEREAL TUMORS, VETERINARY;

EID: 38649113943     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0386-0     Document Type: Article

References (50)

1. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811
2. Onishi H, Kuroki H, Matsumoto K, Baba E, Sasaki N, Kuga H, Tanaka M, Katano M, Morisaki T (2004) Monocyte-derived dendritic cells that capture dead tumor cells secrete IL-12 and TNF-alpha through IL-12/TNF-alpha/NF-kappaB autocrine loop. Cancer Immunol Immunother 53:1093-1100
3. Tourkova IL, Shurin GV, Chatta GS, Perez L, Finke J, Whiteside TL, Ferrone S, Shurin MR (2005) Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides. J Immunol 175:3045-3052
4. Rossi G, Heveker N, Thiele B, Gelderblom H, Steinbach F (1992) Development of a Langerhans cell phenotype from peripheral blood monocytes. Immunol Lett 31:189-197
5. Nimura F, Zhang LF, Okuma K, Tanaka R, Sunakawa H, Yamamoto N, Tanaka Y (2006) Cross-linking cell surface chemokine receptors leads to isolation, activation, and differentiation of monocytes into potent dendritic cells. Exp Biol Med (Maywood) 231:431-443
6. Ferlazzo G, Tsang ML, Moretta L, Melioli G, Steinman RM, Munz C (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195:343-351
7. Taieb J, Chaput N, Menard C, Apetoh L, Ullrich E, Bonmort M, Pequignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Metivier D, Tomasello E, Vivier E, Ghiringhelli F, Martin F, Klatzmann D, Poynard T, Tursz T, Raposo G, Yagita H, Ryffel B, Kroemer G, Zitvogel L (2006) A novel dendritic cell subset involved in tumor immunosurveillance. Nature Med 12:214-219
8. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10-16
9. Aalamian M, Pirtskhalaishvili G, Nunez A, Esche C, Shurin GV, Huland E, Huland H, Shurin MR (2001) Human prostate cancer regulates generation and maturation of monocyte-derived dendritic cells. Prostate 46:68-75
10. Kiertscher SM, Luo J, Dubinett SM, Roth MD (2000) Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells. J Immunol 164:1269-1276
11. Mahanonda R, Sa-Ard-Iam N, Yongvanitchit K, Wisetchang M, Ishikawa I, Nagasawa T, Walsh DS, Pichyangkul S (2002) Upregulation of co-stimulatory molecule expression and dendritic cell marker (CD83) on B cells in periodontal disease. J Periodontal Res 37:177-183
12. Ninomiya T, Akbar SM, Masumoto T, Horiike N, Onji M (1999) Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 31:323-331
13. Babatz J, Rollig C, Oelschlagel U, Zhao S, Ehninger G, Schmitz M, Bornhauser M (2003) Large-scale immunomagnetic selection of CD14+ monocytes to generate dendritic cells for cancer immunotherapy: a phase I study. J Hematother Stem Cell Res 12:515-523
14. Menetrier-Caux C, Montmain G, Dieu MC, Bain C, Favrot MC, Caux C, Blay JY (1998) Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor. Blood 92:4778-4791
15. Um SH, Mulhall C, Alisa A, Ives AR, Karani J, Williams R, Bertoletti A, Behboudi S (2004) {alpha}-Fetoprotein Impairs APC Function and Induces Their Apoptosis. J Immunol 173:1772-1778
16. Katsenelson NS, Shurin GV, Bykovskaia SN, Shogan J, Shurin MR (2001) Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function. Mod Pathol 14:40-45
17. Harizi H, Juzan M, Pitard V, Moreau JF, Gualde N (2002) Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 168:2255-2263
18. Takahashi A, Kono K, Ichihara F, Sugai H, Fujii H, Matsumoto Y (2004) Vascular endothelial growth factor inhibits maturation of dendritic cells induced by lipopolysaccharide, but not by proinflammatory cytokines. Cancer Immunol Immunother 53:543-550
19. Hirano A, Brown WC, Estes DM (1997) Cloning, expression and biological function of the bovine CD40 homologue: role in B-lymphocyte growth and differentiation in cattle. Immunology 90:294-300
20. Chakraborty A, Li L, Chakraborty NG, Mukherji B (1999) Stimulatory and inhibitory maturation of human macrophage-derived dendritic cells. Pathobiology 67:282-286
21. Larmonier N, Marron M, Zeng Y, Cantrell J, Romanoski A, Sepassi M, Thompson S, Chen X, Andreansky S, Katsanis E (2007) Tumor-derived CD4+CD25+ regulatory T cell suppression of dendritic cell function involves TGF- and IL-10. Cancer Immunol Immunotherapy 56:48-59
22. Howell JM, Ishmael J, Joshua JO (1969) Transmissible venereal tumour of dogs. Vet Rec 84:418-419
23. Murgia C, Pritchard J, Kim SY, Fassati A, Weiss RA (2006) Clonal Origin and Evolution of a Transmissible Cancer. Cell 126:477-487
24. Chu RM, Lin CY, Liu CC, Yang SY, Hsiao YW, Hung SW, Pao HN, Liao KW (2001) Proliferation characteristics of canine transmissible venereal tumor. Anticancer Res 21:4017-4024
25. Cohen D (1985) The canine transmissible venereal tumor: a unique result of tumor progression. Adv Cancer Res 43:75-112
26. Hsiao YW, Liao KW, Hung SW, Chu RM (2004) Tumor-infiltrating lymphocyte secretion of IL-6 antagonizes tumor-derived TGF-beta1 and restores the lymphokine-activated killing activity. J Immunol 172:1508-1514
27. Hsiao YW, Liao KW, Hung SW, Chu RM (2002) Effect of tumor infiltrating lymphocytes on the expression of MHC molecules in canine transmissible venereal tumor cells. Vet Immunol Immunopathol 87:19-27
28. Bonnefont-Rebeix C, de Carvalho CM, Bernaud J, Chabanne L, Marchal T, Rigal D (2006) CD86 molecule is a specific marker for canine monocyte-derived dendritic cells. Vet Immunol Immunopathol 109:167-176
29. Wang YS, Chi KH, Liao KW, Liu CC, Cheng CL, Lin YC, Cheng CH, Chu RM (2007) Characterization of canine monocyte-derived dendritic cells with phenotypic and functional differentiation. Can J Vet Res 71:165-174
30. Hagglund HG, McSweeney PA, Mathioudakis G, Bruno B, Georges GE, Gass MJ, Moore P, Sale GE, Storb R, Nash RA (2000) Ex vivo expansion of canine dendritic cells from CD34+ bone marrow progenitor cells. Transplantation 70:1437-1442
31. Liao KW, Hung SW, Hsiao YW, Bennett M, Chu RM (2003) Canine transmissible venereal tumor cell depletion of B lymphocytes: molecule(s) specifically toxic for B cells. Vet Immunol Immunopathol 92:149-162
32. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402-408
33. Nikitina EY, Gabrilovich DI (2001) Combination of gamma-irradiation and dendritic cell administration induces a potent antitumor response in tumor-bearing mice: approach to treatment of advanced stage cancer. Int J Cancer 94:825-833
34. Pinzon-Charry A, Maxwell T, Lopez JA (2005) Dendritic cell dysfunction in cancer: a mechanism for immunosuppression. Immunol Cell Biol 83:451-461
35. Della Bella S, Gennaro M, Vaccari M, Ferraris C, Nicola S, Riva A, Clerici M, Greco M, Villa ML (2003) Altered maturation of peripheral blood dendritic cells in patients with breast cancer. Br J Cancer 89:1463-1472
36. Esche C, Shurin MR, Lotze MT (1997) B16 melanoma induces downregulation of beta2 integrin and ICAM-1 expression on murin dendritic cells. J Investig Dermatol 108:640
37. Chaux P, Favre N, Bonnotte B, Moutet M, Martin M, Martin F (1997) Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors. Adv Exp Med Biol 417:525-528
38. Kato M, Neil TK, Fearnley DB, McLellan AD, Vuckovic S, Hart DN (2000) Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int Immunol 12:1111-1113
39. Mohty M, Jarrossay D, Lafage-Pochitaloff M, Zandotti C, Briere F, de Lamballeri XN, Isnardon D, Sainty D, Olive D, Gaugler B (2001) Circulating blood dendritic cells from myeloid leukemia patients display quantitative and cytogenetic abnormalities as well as functional impairment. Blood 98:3750-3756
40. Vicari AP, Caux C, Trinchieri G (2002) Tumour escape from immune surveillance through dendritic cell inactivation. Semin Cancer Biol 12:33-42
41. Bohnenkamp HR, Burchell JM, Taylor-Papadimitriou J, Noll T (2004) Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cells. J Immunol Methods 294:67-80
42. Muta M, Matsumoto G, Nakashima E, Toi M (2006) Mechanical analysis of tumor growth regression by the cyclooxygenase-2 inhibitor, DFU, in a Walker256 rat tumor model: importance of monocyte chemoattractant protein-1 modulation. Clin Cancer Res 12:264-272
43. Lans TE, Van Horssen R, Eggermont AM, Ten Hagen TL (2004) Involvement of endothelial monocyte activating polypeptide II in tumor necrosis factor-alpha-based anti-cancer therapy. Anticancer Res 24:2243-2248
44. Micheva I, Thanopoulou E, Michalopoulou S, Karakantza M, Kouraklis-Symeonidis A, Mouzaki A, Zoumbos N (2004) Defective tumor necrosis factor alpha-induced maturation of monocyte-derived dendritic cells in patients with myelodysplastic syndromes. Clin Immunol 113:310-317
45. Ito M, Minamiya Y, Kawai H, Saito S, Saito H, Nakagawa T, Imai K, Hirokawa M, Ogawa J (2006) Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node. J Immunol 176:5637-5643
46. Roberts AB, Anzano MA, Meyers CA, Wideman J, Blacher R, Pan YC, Stein S, Lehrman SR, Smith JM, Lamb LC et al (1983) Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry 22:5692-5698
47. Frick JS, Zahir N, Muller M, Kahl F, Bechtold O, Lutz MB, Kirschning CJ, Reimann J, Jilge B, Bohn E, Autenrieth IB (2006) Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: an important role for IL-6. Eur J Immunol 36:1537-1547
48. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990) CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433
49. Duperrier K, Velten FW, Bohlender J, Demory A, Metharom P, Goerdt S (2005) Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes. Mol Immunol 42:1531-1540
50. Velten FW, Duperrier K, Bohlender J, Metharom P, Goerdt S (2004) A gene signature of inhibitory MHC receptors identifies a BDCA3(+) subset of IL-10-induced dendritic cells with reduced allostimulatory capacity in vitro. Eur J Immunol 34:2800-2811